Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.
Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.
Address: Top Floor, 111 Rathmines Road Lr, Dublin 6
Tel: 353 (01) 441 0024
GreenCross Publishing is owned by Graham Cooke.
The Irish Pharmaceutical Healthcare Association (IPHA) has warned that the draft ‘Programme for Government – Our Shared Future’, published today “leaves unresolved the funding crisis for new medicines”.
The Association said that for the last year “there has been a deliberate decision from Government to provide no new funding to the HSE for new medicines”. The IPHA warns that this has created a “backlog of at least 18 new medicines still unavailable for patients”.
“The funding of new medicines is in crisis,” said Mr Oliver O’Connor, CEO of IPHA.
“The new Programme for Government is totally silent on funding new medicines. Without a change in direction from Government, the HSE is still effectively prohibited from paying for new medicines for patients.
“The result is that patients in Ireland are among the last in western Europe to access new innovative treatments. That means doctors are unable to prescribe the newest and best medicines for patients with serious illnesses like cancer, stroke and heart disease. This Programme for Government leaves patients and doctors still waiting.
“In its first Budget, the new Government must put new funding for new medicines on the table. That can be the basis for a new Agreement – a joint funding model recognising that both industry and the State share a responsibility to give patients the same treatment options as their peers in western Europe.
“With the current Agreement on pricing and supply of medicines set to expire, we are working on a co-funding model in which both industry and the State would agree to jointly fund new medicines. That’s the fairest way to ensure patients get timely access to the best medicines,” said Mr O’Connor.
The IMO has commenced a ballot of NCHDs on industrial action up to and including strike...
The National Office of Clinical Audit (NOCA) has announced the publication of the National Paediatric Diabetes...
The ICGP is examining alternative pathways for entry into general practice training as part of efforts...
In December, the HSE released part of an external review into the case of 'Brandon', a...
The evidence on doctor burnout “should scare us and concern us”, the Director of the RCSI...
A review of public health governance structures and addressing “longstanding” IT infrastructure...
Leave a Reply
You must be logged in to post a comment.